X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

1.68
Delayed Data
As of Apr 20
 0.00 / 0.00%
Today’s Change
1.62
Today|||52-Week Range
4.14
-26.64%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close1.68
Today’s open1.71
Day’s range1.64 - 1.71
Volume2,038
Average volume (3 months)8,568
Market cap$8.7M
Data as of 11:28am ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+35.49%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.73

Competitors

 Today’s
change
Today’s
% change
ATOSAtossa Genetics Inc-48.85-93.28%
CYANCyanotech Corp-0.25-5.62%
IBIOIbio Inc-0.01-4.66%
ISRIsoRay Inc+0.00+0.25%
Data as of 4:00pm ET, 04/20/2018

Financials

Last reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$2.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Raanana, Hamerkaz

Forecasts